Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 2,083 Shares

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the firm’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $18.00, for a total value of $37,494.00. Following the sale, the chief accounting officer directly owned 7,108 shares in the company, valued at $127,944. This trade represents a 22.66% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Craig Gracey also recently made the following trade(s):

• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Up 1.5%

Omada Health stock traded up $0.28 during mid-day trading on Wednesday, hitting $18.58. The company had a trading volume of 706,805 shares, compared to its average volume of 1,201,429. The stock has a market cap of $1.10 billion and a price-to-earnings ratio of -68.81. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The business has a fifty day moving average of $16.09 and a 200 day moving average of $14.79.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The business had revenue of $78.05 million during the quarter. Equities analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

OMDA has been the subject of several research reports. Citigroup reissued an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Canaccord Genuity Group set a $24.00 target price on shares of Omada Health in a research report on Friday, May 8th. Morgan Stanley reiterated an “overweight” rating and issued a $30.00 price target on shares of Omada Health in a research report on Monday. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Omada Health in a research note on Thursday, June 4th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.91.

Hedge Funds Weigh In On Omada Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Perceptive Advisors LLC acquired a new position in Omada Health in the 2nd quarter valued at $44,402,000. Millennium Management LLC lifted its stake in shares of Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after acquiring an additional 2,096,705 shares during the period. Divisadero Street Capital Management LP purchased a new stake in shares of Omada Health in the third quarter valued at about $30,510,000. Jefferies Financial Group Inc. acquired a new position in shares of Omada Health during the fourth quarter worth about $16,948,000. Finally, SG Americas Securities LLC purchased a new position in Omada Health during the first quarter worth about $10,401,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.